CDK2 and hepatocellular carcinoma: Following S1P stimulation, the proliferative potential of HCC cells was increased significantly (Figure 5D), and the changes noted in Bcl2, cleaved PARP, cyclin D1, CDK2, and CDK4 expression following regorafenib treatment of the cells were partly diminished (Figure 5E).